AXT’s AI-optics turnaround and InP leadership are compelling, but 39x sales and China export-license risk create an asymmetric downside profile.
Overview
AXT is a compound-semiconductor materials supplier with manufacturing concentrated in Beijing and a leading position in InP substrates used in next-generation optical connectivity. **The operating turnaround is substantial:** Q2 2026 revenue reached a record $47.59 million, up 164.8% year over year and 76.9% sequentially, while non-GAAP gross margin expanded to 45.0% from 8.2% in Q2 2025 and non-GAAP diluted EPS reached $0.19 versus $(0.15). InP revenue alone was $30.70 million. Q3 guidance of $66.0 million in revenue and $0.30–$0.32 of non-GAAP EPS materially exceeds prior consensus. The company has more than $100 million of backlog and plans to more than double InP capacity in 2026 and again in 2027. However, **valuation and geopolitical exposure overwhelm the operational improvement:** at $73.81, AXT trades at approximately 39.4x trailing sales, 35.4x EV/Sales, and 112.3x FY2026 NTM P/E. Every Beijing shipment requires a Chinese export license, with a major regulatory checkpoint on November 27, 2026. The report therefore views the shares as a geopolitically constrained leader with asymmetric downside despite strong AI-optics catalysts.